碘溶液在Graves病全甲状腺切除术中的效果:一项荟萃分析
这项荟萃分析纳入11项研究共2257例Graves病行全甲状腺切除术患者,比较术前使用碘溶液(n=760)与对照组(n=1497)的临床结局。结果显示两组在术中估计出血量、手术时间、内分泌相关并发症、低钙血症、血肿及喉返神经损伤方面均无显著差异。结论提示术前碘溶液与对照组临床结局相似,仍需更大样本的随机对照试验验证。
要点
- 术前碘溶液组与对照组在术中估计出血量、手术时间上无显著差异。
- 两组内分泌相关并发症、低钙血症、血肿及喉返神经损伤风险相似。
- 现有证据不支持术前碘溶液能显著改善Graves病全甲状腺切除术结局。
核心结论
- 术前使用碘溶液与对照组在Graves病全甲状腺切除术后的临床结局相似。
研究设计与样本
- 系统检索Ovid MEDLINE、CINAHL、Ovid Embase和Cochrane Library自建库至2024年8月,PROSPERO注册号CRD42024585797。
- 从2243项研究中筛选出11项符合标准的研究,共2257例Graves病患者,碘溶液组760例,对照组1497例。
主要发现
- 术中估计出血量:均数差-24.6 mL(95%CI -56.2至7.0;I2=82%)。
- 手术时间:均数差-2.3分钟(95%CI -10.6至6.0;I2=68%)。
- 内分泌相关并发症:OR 0.85(95%CI 0.42至1.74;I2=76%)。
- 低钙血症:OR 1.11(95%CI 0.65至1.91;I2=61%)。
- 血肿:OR 1.44(95%CI 0.39至5.29;I2=58%);喉返神经损伤:OR 0.70(95%CI 0.26至1.93;I2=53%)。
临床怎么用
- 对于Graves病行全甲状腺切除术的患者,术前碘溶液的使用应基于个体化评估,现有证据未显示其显著改善临床结局。
局限性
- 研究间存在异质性(如出血量I2=82%、内分泌并发症I2=76%)。
- 作者指出需要更大样本和更严格选择标准的随机对照试验来确认围术期效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Iodine solution has been used preoperatively in patients with Graves disease undergoing a total thyroidectomy to reduce the vascularization and its associated risk of complications. This meta-analysis aimed to investigate the safety and efficacy of preoperative administration of iodine solution in patients with Graves disease undergoing a total thyroidectomy. METHODS: Ovid MEDLINE, CINAHL, Ovid Embase, and the Cochrane Library were searched for articles since its inception to August 2024. The review was registered prospectively on the PROSPERO database (CRD42024585797). RESULTS: From the 2,243 studies screened, 11 studies met the eligibility criteria, with a total of 2,257 patients with Graves disease undergoing a total thyroidectomy either with iodine solution (n = 760) or control (n = 1,497) groups. Our study demonstrated that the iodine solution group had similar outcomes compared with the control group with regard to intraoperative estimated blood loss (mean difference = -24.6 mL, 95% confidence interval: -56.2, 7.0; I2 = 82%), operative time (mean difference = -2.3 minutes, 95% confidence interval: -10.6, 6.0; I2 = 68%), endocrine-related complications (odds ratio = 0.85, 95% confidence interval: 0.42, 1.74; I2 = 76%), hypocalcemia (odds ratio = 1.11, 95% confidence interval: 0.65, 1.91; I2 = 61%), hematoma (odds ratio = 1.44, 95% confidence interval: 0.39, 5.29; I2 = 58%) or recurrent laryngeal nerve injury (odds ratio = 0.70, 95% confidence interval: 0.26, 1.93; I2 = 53%). CONCLUSION: This meta-analysis demonstrates that preoperative iodine solution and control groups had similar clinical outcomes when undergoing total thyroidectomy for Graves disease. Further randomized control trials with larger samples and robust selection criteria are necessary to ascertain the perioperative effects of iodine solution in total thyroidectomy for patients with Graves disease.
引用
- Haroon AM, Ghani A, Ayesh AR, et al. The effect of iodine solution in total thyroidectomy for patients with Graves disease: A meta-analysis. Surgery. 2025. PMID: 41351925. doi:10.1016/j.surg.2025.109926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。